The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk of HCC recurrence with cellular immunotherapy following radiofrequency ablation.
Jiuwei Cui
No relevant relationships to disclose
Wei Li
No relevant relationships to disclose
Nanya Wang
No relevant relationships to disclose
Hengjun Zhao
No relevant relationships to disclose
Haofan Jin
No relevant relationships to disclose
Chao Niu
No relevant relationships to disclose
Guanjun Wang
No relevant relationships to disclose